Secondary navigation: People section
Executive Director – ABPI Research, Medical & Innovation
+44 207 747 1408
Association of the British Pharmaceutical Industry (ABPI)
7th Floor, Southside
105 Victoria Street
London SW1E 6QT
Dr Virginia (Ginny) Acha has worked in private sector and academia throughout her career, combining her interests in science policy research and performance within and across organizations.
Dr Acha has taken up the position of ABPI’s Executive Director - Research Medical and Innovation (RM&I) in March 2015, after two years at Amgen as Director, Global Regulatory and R&D policy - Europe, Middle East and Africa. She holds the chair for the Pharmacovigilance working group in the IFPMA Bio therapeutics Committee, and until recently was the Vice-Chair for the European Biopharmaceutical Enterprises (EBE) Biosimilars Task Force and the lead for the EFPIA Regulatory Network supporting Turkey.
Prior to her post at Amgen, Dr Acha spent nearly 5 years at Pfizer working on policy development and engagement in a number of domains, including science, innovation and access and choice in healthcare. In this role, she undertook analysis and policy development in key areas of the business including biosimilars, the value of innovation, personalised medicine and healthcare markets and procurement methods.
Dr Acha entered the pharmaceutical industry after a decade in academia where she held posts on innovation strategy at Imperial College London Business School, the Science Policy Research Unit (SPRU) at the University of Sussex, the Centre for Research in Innovation Management (CENTRIM) at the University of Brighton, as well as a post-doctoral fellowship at London Business School. She is also a Visiting Researcher in the Innovation & Entrepreneurship Department at Imperial College Business School London.